S1868 Major Adverse Cardiovascular Events in Ulcerative Colitis Patients Treated with Vedolizumab, Tofacitinib, or Mesalamine
Year: 2025
Type: conference-abstract
Authors: Julton Tomanguillo, Nisar Amin, Ebubekir Daglilar, Harleen Chela
Language: English
Topic: Inflammatory Bowel Disease
Subfield: Genetics
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W7113896812
Cites:
Cited by:
Related to:
